143 related articles for article (PubMed ID: 28416640)
21. Challenges in the identification of MSH6-associated colorectal cancer: rectal location, less typical histology, and a subset with retained mismatch repair function.
Klarskov L; Holck S; Bernstein I; Okkels H; Rambech E; Baldetorp B; Nilbert M
Am J Surg Pathol; 2011 Sep; 35(9):1391-9. PubMed ID: 21836479
[TBL] [Abstract][Full Text] [Related]
22. Deletion in HSP110 T
Kim KJ; Lee TH; Kim JH; Cho NY; Kim WH; Kang GH
Hum Pathol; 2017 Sep; 67():109-118. PubMed ID: 28811251
[TBL] [Abstract][Full Text] [Related]
23. Tissue identity testing of cancer by short tandem repeat polymorphism: pitfalls of interpretation in the presence of microsatellite instability.
Much M; Buza N; Hui P
Hum Pathol; 2014 Mar; 45(3):549-55. PubMed ID: 24444463
[TBL] [Abstract][Full Text] [Related]
24. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
[TBL] [Abstract][Full Text] [Related]
25. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
[TBL] [Abstract][Full Text] [Related]
26. Microsatellite instability and DNA mismatch repair deficiency testing in hereditary and sporadic gastrointestinal cancers.
Gologan A; Sepulveda AR
Clin Lab Med; 2005 Mar; 25(1):179-96. PubMed ID: 15749237
[TBL] [Abstract][Full Text] [Related]
27. A ten markers panel provides a more accurate and complete microsatellite instability analysis in mismatch repair-deficient colorectal tumors.
Agostini M; Enzo MV; Morandi L; Bedin C; Pizzini S; Mason S; Bertorelle R; Urso E; Mescoli C; Lise M; Pucciarelli S; Nitti D
Cancer Biomark; 2010; 6(1):49-61. PubMed ID: 20164541
[TBL] [Abstract][Full Text] [Related]
28. Differences and evolution of the methods for the assessment of microsatellite instability.
Laghi L; Bianchi P; Malesci A
Oncogene; 2008 Oct; 27(49):6313-21. PubMed ID: 18679418
[TBL] [Abstract][Full Text] [Related]
29. Incidence of microsatellite instability in synchronous tumors of the ovary and endometrium.
Shannon C; Kirk J; Barnetson R; Evans J; Schnitzler M; Quinn M; Hacker N; Crandon A; Harnett P
Clin Cancer Res; 2003 Apr; 9(4):1387-92. PubMed ID: 12684409
[TBL] [Abstract][Full Text] [Related]
30. Detection of coding microsatellite frameshift mutations in DNA mismatch repair-deficient mouse intestinal tumors.
Woerner SM; Tosti E; Yuan YP; Kloor M; Bork P; Edelmann W; Gebert J
Mol Carcinog; 2015 Nov; 54(11):1376-86. PubMed ID: 25213383
[TBL] [Abstract][Full Text] [Related]
31. Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients.
de Leeuw WJ; Dierssen J; Vasen HF; Wijnen JT; Kenter GG; Meijers-Heijboer H; Brocker-Vriends A; Stormorken A; Moller P; Menko F; Cornelisse CJ; Morreau H
J Pathol; 2000 Nov; 192(3):328-35. PubMed ID: 11054716
[TBL] [Abstract][Full Text] [Related]
32. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.
Hampel H; Frankel W; Panescu J; Lockman J; Sotamaa K; Fix D; Comeras I; La Jeunesse J; Nakagawa H; Westman JA; Prior TW; Clendenning M; Penzone P; Lombardi J; Dunn P; Cohn DE; Copeland L; Eaton L; Fowler J; Lewandowski G; Vaccarello L; Bell J; Reid G; de la Chapelle A
Cancer Res; 2006 Aug; 66(15):7810-7. PubMed ID: 16885385
[TBL] [Abstract][Full Text] [Related]
33. [Immunohistochemical examination of MSH2, PMS2, MLH1, MSH6 compared with the analysis of microsatellite instability in colon adenocarcinoma].
Raskin GA; Ianus GA; Kornilov AV; Orlova RV; Petrov SV; Protasova AÉ; Pozharisskiĭ KM; Imianitov EN
Vopr Onkol; 2014; 60(2):47-50. PubMed ID: 24919261
[TBL] [Abstract][Full Text] [Related]
34. Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas.
Catasús L; Bussaglia E; Rodrguez I; Gallardo A; Pons C; Irving JA; Prat J
Hum Pathol; 2004 Nov; 35(11):1360-8. PubMed ID: 15668893
[TBL] [Abstract][Full Text] [Related]
35. Taiwan hospital-based detection of Lynch syndrome distinguishes 2 types of microsatellite instabilities in colorectal cancers.
Chang SC; Lin PC; Yang SH; Wang HS; Liang WY; Lin JK
Surgery; 2010 May; 147(5):720-8. PubMed ID: 20045164
[TBL] [Abstract][Full Text] [Related]
36. Microsatellite instability analysis and its correlation with hMLH1 repair gene hypermethylation status in esophageal pathologies including cancers.
Vasavi M; Kiran V; Ravishankar B; Prabhakar B; Ahuja YR; Hasan Q
Cancer Biomark; 2010; 7(1):1-10. PubMed ID: 21045259
[TBL] [Abstract][Full Text] [Related]
37. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.
Lawes DA; Pearson T; Sengupta S; Boulos PB
Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253
[TBL] [Abstract][Full Text] [Related]
38. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer.
Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E
Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847
[TBL] [Abstract][Full Text] [Related]
40. Yield of routine molecular analyses in colorectal cancer patients ≤70 years to detect underlying Lynch syndrome.
van Lier MG; Leenen CH; Wagner A; Ramsoekh D; Dubbink HJ; van den Ouweland AM; Westenend PJ; de Graaf EJ; Wolters LM; Vrijland WW; Kuipers EJ; van Leerdam ME; Steyerberg EW; Dinjens WN;
J Pathol; 2012 Apr; 226(5):764-74. PubMed ID: 22081473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
